Publication | Closed Access

Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age

Breast OncologyMedicinePrognostic ValueCancer GrowthPathologyBreast CancerOncologyRadiation OncologyTumor MicroenvironmentCancer ResearchEndocrine-related CancerPhosphohistone H3